Cohort description: The Danish study of functional disorders

Clinical Epidemiology

Volumn 9, Issue , 2017, Pages 127-139

  Dantoft, Thomas Meinertz ^a   Ebstrup, Jeanette Frost ^a   Linneberg, Allan ^a,b,c   Skovbjerg, Sine ^a   Madsen, Anja Lykke ^a   Mehlsen, Jesper ^d   Brinth, Louise ^d   Eplov, Lene Falgaard ^e   Carstensen, Tina Wisbech ^f,g   Schroder, Andreas ^f,g   Fink, Per Klausen ^f,g   Mortensen, Erik Lykke ^h   Hansen, Torben ⁱ   Pedersen, Oluf ⁱ   Jørgensen, Torben ^a,b,j  

^a Research Centre for Prevention and Health   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e Child and Adolescent Mental Health Center   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h Department of Public Health and Center for Healthy Aging ^*  (Denmark)

ⁱ Capital Region   (Denmark)

^j AALBORG UNIVERSITY   (Denmark)

more..

Author keywords

Epidemiology; Functional somatic syndromes; Longitudinal cohort study; Medically unexplained symptoms; Pathophysiology; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC FATIGUE SYNDROME; COHORT ANALYSIS; DISTRESS SYNDROME; EPIDEMIOLOGICAL DATA; FEMALE; FIBROMYALGIA; FOLLOW UP; GENE FUNCTION; HEART RATE VARIABILITY; HUMAN; INCIDENCE; IRRITABLE COLON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CHEMICAL SENSITIVITY; NOCICEPTION; POPULATION RESEARCH; PREVALENCE; RANGE OF MOTION; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; WHIPLASH INJURY;

EID: 85015720316     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S129335     Document Type: Article

References (73)

1. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(9182):936-939.
2. Rosmalen JG, Tak LM, de Jonge P. Empirical foundations for the diagnosis of somatization: implications for DSM-5. Psychol Med. 2011;41(6):1133-1142.
3. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369(9565):946-955.
4. Creed F, Guthrie E, Fink P, et al. Is there a better term than “medically unexplained symptoms”? J Psychosom Res. 2010;68(1):5-8.
5. Creed F, Henningsen P, Fink P. Medically Unexplained Symptoms, Somatisation, and Bodily Distress: Developing Better Clinical Services. Cambridge: Cambridge University Press; 2011.
6. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med. 2007;69(1):30-39.
7. Kay L, Jorgensen T., Redefining abdominal syndromes. Results of a population-based study. Scand J Gastroenterol. 1996;31(5):469-475.
8. Kay L, Jorgensen T, Lanng C. Irritable bowel syndrome: which definitions are consistent? J Intern Med. 1998;244(6):489-494.
9. Videlock EJ, Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin North Am. 2007;36(3):665-685.
10. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-958.
11. Schroder A, Fink P. The proposed diagnosis of somatic symptom disorders in DSM-V: two steps forward and one step backward? J Psychosom Res. 2010;68(1):95-96 [author reply 99-100].
12. Carruthers BB, Jain AK, De Meirleir KL, et al. Myaligic encephalomyelitis/ chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11(1):7.
13. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006;367(9507):346-355.
14. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953-959.
15. Spitzer WO, Skovron ML, Salmi LR, et al. Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining “whiplash” and its management. Spine (Phila Pa 1976). 1995;20(Suppl 8):1S-73S.
16. Dantoft TM, Andersson L, Nordin S, Skovbjerg S. Chemical intolerance. Curr Rheumatol Rev. 2015;11(2):167-184.
17. Budtz-Lilly A, Schroder A, Rask MT, Fink P, Vestergaard M, Rosendal M. Bodily distress syndrome: a new diagnosis for functional disorders in primary care? BMC Fam Pract. 2015;16:180.
18. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999-1008.
19. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951;41(3):279-281.
20. Niiranen TJ, Vasan RS. Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches. Expert Rev Cardiovasc Ther. 2016;14(7):855-869.
21. Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39(3):497-505.
22. Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Hauser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011;38(10):2238-2246.
23. Joustra ML, Janssens KA, Bultmann U, Rosmalen JG., Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines. J Psychosom Res. 2015;79(2):94-99.
24. Stolk RP, Rosmalen JG, Postma DS, et al. Universal risk factors for multifactorial diseases: lifelines: a three-generation population-based study. Eur J Epidemiol. 2008;23(1):67-74.
25. Creed FH, Davies I, Jackson J, et al. The epidemiology of multiple somatic symptoms. J Psychosom Res. 2012;72(4):311-317.
26. Rosmalen JG. The way forward: a case for longitudinal population-based studies in the field of functional somatic syndromes. J Psychosom Res. 2010;68(5):399-401.
27. Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015;67(2):568-575.
28. Jones GT. Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes. Curr Rheumatol Rev. 2016; 12(2):140-153.
29. Creed F. Exploding myths about medically unexplained symptoms. J Psychosom Res. 2016;85:91-93.
30. Yunus MB. Editorial review: an update on central sensitivity syndromes and the issues of nosology and psychobiology. Curr Rheumatol Rev. 2015;11(2):70-85.
31. Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol. 2015;12(10):592-605.
32. Christensen SS, Frostholm L, Ornbol E, Schroder A. Changes in illness perceptions mediated the effect of cognitive behavioural therapy in severe functional somatic syndromes. J Psychosom Res. 2015;78(4): 363-370.
33. Rief W, Broadbent E. Explaining medically unexplained symptomsmodels and mechanisms. Clin Psychol Rev. 2007;27(7):821-841.
34. Korkina L, Scordo MG, Deeva I, Cesareo E, De Luca C. The chemical defensive system in the pathobiology of idiopathic environmentassociated diseases. Curr Drug Metab. 2009;10(8):914-931.
35. Fink P, Rosendal M. Recent developments in the understanding and management of functional somatic symptoms in primary care. Curr Opin Psychiatry. 2008;21(2):182-188.
36. Thuesen BH, Cerqueira C, Aadahl M, et al. Cohort profile: the Health2006 cohort, research centre for prevention and health. Int J Epidemiol. 2014;43(2):568-575.
37. Eplov LF, Petersen J, Jorgensen T, et al. The Mental Vulnerability Questionnaire: a psychometric evaluation. Scand J Psychol. 2010;51(6):548-554.
38. Toft U, Kristoffersen LH, Lau C, Borch-Johnsen K, Jorgensen T. The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study. Eur J Clin Nutr. 2007;61(2):270-278.
39. Costa PT Jr., McCrae RR. Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess. 1995;64(1):21-50.
40. Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139(5):439-457.
41. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396.
42. Seery MD, Leo RJ, Holman EA, Silver RC. Lifetime exposure to adversity predicts functional impairment and healthcare utilization among individuals with chronic back pain. Pain. 2010;150(3):507-515.
43. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147-153.
44. Jackson C. The Chalder Fatigue Scale (CFQ 11). Occup Med (Lond). 2015;65(1):86.
45. Olsen LR, Mortensen EL, Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand. 2004;110(3):161-162.
46. Fink P, Ewald H, Jensen J, et al. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a sevenitem scale for hypochondriasis and somatization. J Psychosom Res. 1999;46(3):261-273.
47. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631-637.
48. Kori SH, Miller RP, Todd DD. Kinesiophobia: a new view of chronic pain behaviour. Pain Management. 1990;3:35-43.
49. Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448-453.
50. White KP, Harth M, Speechley M, Ostbye T. Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. J Rheumatol. 1999;26(4):880-884.
51. Berg ND, Linneberg A, Dirksen A, Elberling J. Prevalence of selfreported symptoms and consequences related to inhalation of airborne chemicals in a Danish general population. Int Arch Occup Environ Health. 2008;81(7):881-887.
52. Berg ND, Linneberg A, Dirksen A, Elberling J. Phenotypes of individuals affected by airborne chemicals in the general population. Int Arch Occup Environ Health. 2009;82(4):509-517.
53. Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68(5):415-426.
54. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589-593.
55. Osler M, Linneberg A, Glumer C, Jorgensen T. The cohorts at the Research Centre for Prevention and Health, formerly ‘The Glostrup Population Studies’. Int J Epidemiol. 2011;40(3):602-610.
56. Aadahl M, Zacho M, Linneberg A, Thuesen BH, Jorgensen T. Comparison of the Danish step test and the watt-max test for estimation of maximal oxygen uptake: the Health2008 study. Eur J Prev Cardiol. 2013;20(6):1088-1094.
57. Kasch H, Bach FW, Jensen TS. Handicap after acute whiplash injury: a 1-year prospective study of risk factors. Neurology. 2001;56(12):1637-1643.
58. Youdas JW, Carey JR, Garrett TR. Reliability of measurements of cervical spine range of motion-comparison of three methods. Phys Ther. 1991; 71(2):98-104.
59. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611–615.
60. Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010;6(10):599–606.
61. Yarnitsky D, Bouhassira D, Drewes AM, et al. Recommendations on practice of conditioned pain modulation (CPM) testing. Eur J Pain. 2015;19(6):805–806.
62. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. Circulation. 1996; 93(5):1043–1065.
63. Van Cauwenbergh D, Nijs J, Kos D, Van Weijnen L, Struyf F, Meeus M. Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: a systematic literature review. Eur J Clin Invest. 2014;44(5):516–526.
64. Peng RC, Yan WR, Zhou XL, Zhang NL, Lin WH, Zhang YT. Timefrequency analysis of heart rate variability during the cold pressor test using a time-varying autoregressive model. Physiol Meas. 2015;36(3):441–452.
65. Eliasen M, Kreiner S, Ebstrup JF, et al. Somatic symptoms: prevalence, co-occurrence and associations with self-perceived health and limitations due to physical health–a Danish population-based study. PLoS One. 2016;11(3):e0150664.
66. Martinez-Martinez LA, Mora T, Vargas A, Fuentes-Iniestra M, Martinez-Lavin M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case–control studies. J Clin Rheumatol. 2014;20(3):146–150.
67. Tak LM, Riese H, de Bock GH, Manoharan A, Kok IC, Rosmalen JG. As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol. 2009;82(2):101–110.
68. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15): 1547–1555.
69. Lewis GN, Rice DA, McNair PJ. Conditioned pain modulation in populations with chronic pain: a systematic review and meta-analysis. J Pain. 2012;13(10):936–944.
70. Chalder T, Goldsmith KA, White PD, Sharpe M, Pickles AR. Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial. Lancet Psychiatry. 2015;2(2):141–152.
71. Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14(7): 502–511.
72. Carroll LJ, Holm LW, Ferrari R, Ozegovic D, Cassidy JD. Recovery in whiplash-associated disorders: do you get what you expect? J Rheumatol. 2009;36(5):1063–1070.
73. Heinsvig Poulsen C, Falgaard Eplov L, Hjorthoj C, et al. Gastrointestinal symptoms related to the irritable bowel syndrome – a longitudinal population- based register study. Scand J Gastroenterol. 2016;51(4):420–426.